Pear Therapeutics Files for Chapter 11, Seeking to Sell Assets Through Sales Process
Pear Therapeutics, a company focused on developing and commercializing software-based medicines called prescription digital therapeutics, voluntarily filed for protection under Chapter 11 of the U.S. Bankruptcy Code.
April 10, 2023
Foley Hoag | Gibbons | MTS Health Partners | Pear Therapeutics | Sonoran Capital Advisors
Ian Koplin